Senti Biosciences Holdings, Inc. (SNTI)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Senti Biosciences Holdings, Inc. reported revenue of $22.0K. The company ran a net loss, with a net margin of -279263.6%. It held $51.22M in total assets against $45.63M in total liabilities.
Key ratios (FY2025)
-312631.8%
Operating margin
-279263.6%
Net margin
-1099.3%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Revenue | $22.0K | $0 | $1.98M | $3.29M | $2.29M | — |
| Operating Income | -$68.78M | -$61.04M | -$92.73M | -$62.08M | -$40.45M | — |
| Net Income | -$61.44M | -$52.79M | -$71.06M | -$58.21M | -$55.32M | — |
| EPS (Diluted) | $-2.73 | $-12.03 | $-16.01 | $-2.23 | $-19.00 | — |
| Total Assets | $51.22M | $97.84M | $119.48M | $180.79M | $96.70M | — |
| Total Liabilities | $45.63M | $47.09M | $52.57M | $53.53M | $36.33M | — |
| Shareholders' Equity | $5.59M | $25.65M | $66.91M | $127.26M | -$111.46M | -$58.71M |
| Cash & Equivalents | $16.42M | $48.28M | $35.93M | $57.62M | $56.03M | — |
| Operating Cash Flow | -$43.44M | -$41.40M | -$52.40M | -$34.90M | -$34.63M | — |
| Capital Expenditures | $196.0K | $26.0K | $12.04M | $41.37M | $5.54M | — |
| Shares Outstanding | 30.88M | 4.83M | 4.57M | 44.06M | 2.97M | — |